GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

TELA · Mar 31, 2024

TELA Bio, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]

Inspectable configuration

State dimensions

Filing0001558370-24-007784General Corporate

Debt relative to revenueRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.debt_to_revenue

244.93% · OPTIONAL · NOT_ENOUGH_HISTORY

Capex intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1.83% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-86.63% · OPTIONAL · NOT_ENOUGH_HISTORY

Inventory pressureRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

81.92% · OPTIONAL · NOT_ENOUGH_HISTORY

Gross marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.gross_margin

68.28% · CORE · NOT_ENOUGH_HISTORY

Operating marginRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.operating_margin

-29.07% · CORE · NOT_ENOUGH_HISTORY

R&D intensityRAWCurrent state valid · history insufficient

Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

14.41% · OPTIONAL · NOT_ENOUGH_HISTORY

SBC intensityRAWCurrent state valid · history insufficient

Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

6.64% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesHistory building

Jun 30, 20230/8 normalizedLevel 3 Sep 30, 20230/8 normalizedLevel 3 Dec 31, 20230/8 normalizedLevel 3 Mar 31, 20240/8 normalizedLevel 3 Jun 30, 20240/9 normalizedLevel 3 Sep 30, 20240/9 normalizedLevel 3 Dec 31, 20240/9 normalizedLevel 3 Mar 31, 20250/9 normalizedLevel 3 Jun 30, 20258/9 normalizedLevel 3 Sep 30, 20257/8 normalizedLevel 3 Dec 31, 20257/8 normalizedLevel 3 Mar 31, 20267/8 normalizedLevel 3 Jun 30, 20268/8 normalizedLevel 3

Period transition

What moved in the state?

Balance Sheet Leverage Increased

Previous: 69.31%
Current: 244.93%
Delta: 175.61%

Capex Intensity Increased

Previous: 1.05%
Current: 1.83%
Delta: 0.79%

Cash Generation Decreased

Previous: -69.90%
Current: -86.63%
Delta: -16.74%

Inventory Pressure Increased

Previous: 22.52%
Current: 81.92%
Delta: 59.41%

Margin Decreased

Previous: 68.62%
Current: 68.28%
Delta: -0.35%

Profitability Increased

Previous: -75.40%
Current: -29.07%
Delta: 46.34%

R And D Intensity Decreased

Previous: 16.46%
Current: 14.41%
Delta: -2.04%

Sbc Intensity Decreased

Previous: 8.61%
Current: 6.64%
Delta: -1.97%

Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.

Research Graph

Related governed research

Transitioned To · TELA Fundamental State →Has State · TELA Bio, Inc. →Transitioned To · TELA Fundamental State →Transitioned To · TELA BALANCE_SHEET_LEVERAGE_INCREASED →Transitioned To · TELA CAPEX_INTENSITY_INCREASED →Transitioned To · TELA CASH_GENERATION_DECREASED →Transitioned To · TELA INVENTORY_PRESSURE_INCREASED →Transitioned To · TELA MARGIN_DECREASED →Transitioned To · TELA PROFITABILITY_INCREASED →Transitioned To · TELA R_AND_D_INTENSITY_DECREASED →Transitioned To · TELA SBC_INTENSITY_DECREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.